Daam2 driven degradation of VHL promotes gliomagenesis

Wenyi Zhu, Saritha Krishna, Cristina Garcia, Chia Ching John Lin, Bartley D. Mitchell, Kenneth L. Scott, Carrie A. Mohila, Chad J. Creighton, Seung Hee Yoo, Hyun Kyoung Lee, Benjamin Deneen

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Von Hippel-Landau (VHL) protein is a potent tumor suppressor regulating numerous pathways that drive cancer, but mutations in VHL are restricted to limited subsets of malignancies. Here we identified a novel mechanism for VHL suppression in tumors that do not have inactivating mutations. Using developmental processes to uncover new pathways contributing to tumorigenesis, we found that Daam2 promotes glioma formation. Protein expression screening identified an inverse correlation between Daam2 and VHL expression across a host of cancers, including glioma. These in silico insights guided corroborating functional studies, which revealed that Daam2 promotes tumorigenesis by suppressing VHL expression. Furthermore, biochemical analyses demonstrate that Daam2 associates with VHL and facilitates its ubiquitination and degradation. Together, these studies are the first to define an upstream mechanism regulating VHL suppression in cancer and describe the role of Daam2 in tumorigenesis.

Original languageEnglish (US)
Article numbere31926
StatePublished - Oct 20 2017

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)


Dive into the research topics of 'Daam2 driven degradation of VHL promotes gliomagenesis'. Together they form a unique fingerprint.

Cite this